262 related articles for article (PubMed ID: 7756201)
1. Temporising management of severe pre-eclampsia with and without the HELLP syndrome.
Visser W; Wallenburg HC
Br J Obstet Gynaecol; 1995 Feb; 102(2):111-7. PubMed ID: 7756201
[TBL] [Abstract][Full Text] [Related]
2. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome.
van Pampus MG; Wolf H; Westenberg SM; van der Post JA; Bonsel GJ; Treffers PE
Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):31-6. PubMed ID: 9481543
[TBL] [Abstract][Full Text] [Related]
3. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term.
Visser W; Wallenburg HC
Eur J Obstet Gynecol Reprod Biol; 1995 Dec; 63(2):147-54. PubMed ID: 8903771
[TBL] [Abstract][Full Text] [Related]
4. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?
Abramovici D; Friedman SA; Mercer BM; Audibert F; Kao L; Sibai BM
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):221-5. PubMed ID: 9914607
[TBL] [Abstract][Full Text] [Related]
5. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation.
Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
Am J Obstet Gynecol; 2000 Dec; 183(6):1475-9. PubMed ID: 11120513
[TBL] [Abstract][Full Text] [Related]
6. [Maternal and perinatal surgical complications in low platelet count for HELLP syndrome in severe preeclampsia-eclampsia in intensive care].
Basavilvazo Rodríguez A; Pacheco Pérez C; Lemus Rocha R; Martínez Pérez JM; Martínez Martínez A; Hernández-Valencia M
Ginecol Obstet Mex; 2003 Aug; 71():379-86. PubMed ID: 14619691
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia.
Ganzevoort W; Rep A; Bonsel GJ; Fetter WP; van Sonderen L; De Vries JI; Wolf H;
BJOG; 2005 Oct; 112(10):1358-68. PubMed ID: 16167938
[TBL] [Abstract][Full Text] [Related]
8. Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia.
Visser W; van Pampus MG; Treffers PE; Wallenburg HC
Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 53(3):175-81. PubMed ID: 8200464
[TBL] [Abstract][Full Text] [Related]
9. [The impact of pregnancy-prolonging management on maternal and neonatal morbidity in HELLP syndrome].
Hagen A; Ebert A; Lange J; Zemlin M; Hopp H
Zentralbl Gynakol; 2001 Sep; 123(9):513-9. PubMed ID: 11709744
[TBL] [Abstract][Full Text] [Related]
10. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome?
Guzel AI; Kuyumcuoglu U; Celik Y
Arch Gynecol Obstet; 2011 Jun; 283(6):1227-32. PubMed ID: 20526778
[TBL] [Abstract][Full Text] [Related]
11. [Management of HELLP syndrome before 32 weeks of amenorrhea. 22 cases].
Audibert F; Coffineau A; Edouard D; Brivet F; Ville Y; Frydman R; Fernandez H
Presse Med; 1996 Feb; 25(6):235-9. PubMed ID: 8729324
[TBL] [Abstract][Full Text] [Related]
12. [HELLP syndrome and pregnancy hypertension: severity? Anesthetic management].
el Hairy A; Saint-Maurice C
Cah Anesthesiol; 1994; 42(5):613-8. PubMed ID: 7728606
[TBL] [Abstract][Full Text] [Related]
13. Microcirculation in women with severe pre-eclampsia and HELLP syndrome: a case-control study.
Cornette J; Herzog E; Buijs EA; Duvekot JJ; Rizopoulos D; Hop WC; Tibboel D; Steegers EA
BJOG; 2014 Feb; 121(3):363-70. PubMed ID: 24206102
[TBL] [Abstract][Full Text] [Related]
14. [HELLP syndrome--metamorphosis of pre-eclampsia].
Loos W; von Rath W
Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):581-5. PubMed ID: 1294430
[TBL] [Abstract][Full Text] [Related]
15. HELLP syndrome: the experience at Ile-Ife, Nigeria.
Makinde ON; Adegoke OA; Adediran IA; Ndububa DA; Adeyemi AB; Owolabi AT; Kuti O; Orji EO; Salawu L
J Obstet Gynaecol; 2009 Apr; 29(3):195-9. PubMed ID: 19358023
[TBL] [Abstract][Full Text] [Related]
16. Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes.
Aydin S; Ersan F; Ark C; Arıoğlu Aydın C
J Obstet Gynaecol Res; 2014 Apr; 40(4):932-40. PubMed ID: 24612188
[TBL] [Abstract][Full Text] [Related]
17. Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients.
Hanff LM; Vulto AG; Bartels PA; Roofthooft DW; Bijvank BN; Steegers EA; Visser W
J Hypertens; 2005 Dec; 23(12):2319-26. PubMed ID: 16269975
[TBL] [Abstract][Full Text] [Related]
18. [The HELLP syndrome. Notes on its pathogenesis and treatment].
D'Anna R
Minerva Ginecol; 1996 Apr; 48(4):147-54. PubMed ID: 8767557
[TBL] [Abstract][Full Text] [Related]
19. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome.
Gul A; Cebeci A; Aslan H; Polat I; Ozdemir A; Ceylan Y
Gynecol Obstet Invest; 2005; 59(2):113-8. PubMed ID: 15591806
[TBL] [Abstract][Full Text] [Related]
20. Partial HELLP Syndrome: maternal and perinatal outcome.
Abbade JF; Peraçoli JC; Costa RA; Calderon Ide M; Borges VT; Rudge MV
Sao Paulo Med J; 2002 Nov; 120(6):180-4. PubMed ID: 12563425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
